While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: SGCTL-NT-pRSGT16
$300.00
Tet-inducible non-targeting sgRNA control in a lentiviral vector (no Cas9). The tet-inducible U6 promoter drives sgRNA expression and is responsive to the tetracycline analog doxocycline. Vector is available with either GFP or RFP fluorescence and puro selection.